Masaru Matsuda's Net Worth
$3.85 Million
Who is Masaru Matsuda?
Masaru Matsuda has an estimated net worth of $3.85 Million. This is based on reported shares across multiple companies, which include Arcutis Biotherapeutics, Inc., and HALOZYME THERAPEUTICS, INC..
SEC CIK
Masaru Matsuda's CIK is 0001798679
Past Insider Trading and Trends
2024 was Masaru Matsuda's most active year for acquiring shares with 6 total transactions. Masaru Matsuda's most active month to acquire stocks was the month of January. 2021 was Masaru Matsuda's most active year for disposing of shares, totalling 6 transactions. Masaru Matsuda's most active month to dispose stocks was the month of January. 2023 saw Masaru Matsuda paying a total of $9,333.94 for 88,013 shares, this is the most they've acquired in one year. In 2021 Masaru Matsuda cashed out on 25,931 shares for a total of $408,148.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.74% | -5.01K |
$8.68 | -$43,551.26 | 178.27K |
Scheduled
|
Nov 4
| ||
Form 4
| +1.67% | 3.1K |
$9.01 | -$15,988.13 | 188.51K |
Scheduled
|
May 27 - May 28
| ||
Form 4
| -2.63% | -5.02K |
$8.74 | -$43,828.80 | 185.41K |
Scheduled
|
May 2
| ||
Form 4
| -1.94% | -3.76K |
$11.12 | -$41,815.71 | 190.42K |
Scheduled
|
Mar 4
| ||
Form 4
| +160.18% | 119.55K |
—
|
—
| 194.18K |
Feb 13
| |||
Form 4
| +60.04% | 28K |
—
|
—
| 74.63K |
Jan 12
| |||
Form 4
| +6.94% | 3.02K |
$1.98 | -$3,661.15 | 46.63K |
Nov 18 - Nov 21
| |||
Form 4
| +11.53% | 4.51K |
$7.09 | -$4,944.27 | 43.61K |
May 27 - May 31
| |||
Form 4
| +100.16% | 19.57K |
$15.83 | -$22,695.79 | 39.1K |
Scheduled
|
Mar 2
| ||
Form 4
| +19.26% | 3.15K |
$18.19 | -$31,288.86 | 19.54K |
Nov 18 - Nov 21
| |||
Form 4
| +23.16% | 3.08K |
$19.73 | -$35,418.58 | 16.38K |
May 27 - Jun 2
| |||
Form 4
|
∞
| 13.3K |
—
|
—
| 13.3K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS, INC. (HALO) Snapshot price: $59.21
SVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.94% | 3.47K |
$42.22 | -$144,054.64 | 20.05K |
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +44.89% | 5.14K |
$50.30 | -$264,094.28 | 16.58K |
Feb 10 - Feb 12
| |||
Form 4
| +64.92% | 4.5K |
$27.70 | -$65,926.00 | 11.44K |
Sep 4
| |||
Form 4
| +54.56% | 2.45K |
$20.00 | -$33,620.00 | 6.94K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||